German healthcare investor SHS Capital has acquired a majority stake in Dutch firm CAM Bioceramics to support and accelerate future growth. The investment, from the SHS VI fund, also included ING Corporate Investments and other co-investors.
Leiden-based CAM Bioceramics develops calcium phosphate solutions for medtech and life-science applications including orthobiological HA coating powder for orthopaedic, dental and spinal implants, bone graft substitutes, excipients and (CaPs) particles for injectable dermal fillers.
No financial details of the deal were disclosed but its said that ‘the existing owners rolled-over a significant stake in the company' and that the the management team will stay intact.
"We are delighted to have SHS and ING Corporate Investments on board, hence enabling CAM Bioceramics to serve our customers even better and to grow even faster. The existing shareholders and the management team have consciously looked for the best partners to secure continuity and get access to additional and complementary business development opportunities. The partnership with SHS and ING is a validation of our strategy and capabilities and will fuel the company’s growth even further. The Management Team will remain fully intact and will continue to provide the best Customer Satisfaction possible to remain or to become your trusted partner for innovative calcium phosphate solutions and services worldwide," says CAM Shareholder and CEO Caspar J Hogeboom.
"SHS is very happy to be part of this exciting partnership and we look forward to continue working together with CAM and its management team and employees as well as with the existing shareholders, ING and our co-investors. Based on the strong existing customer base and the outstanding capabilities of CAM, we are convinced that we can help to create additional collaboration opportunities and thus support the company in its further growth. The investment in CAM is already the third investment from our newly launched sixth fund generation and another opportunity to be involved in the establishment and further development of a European healthcare champion," says SHS Managing Partner Manfred Ulmer-Weber.
Would you like to write the first comment?
Login to post comments